TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Abera Bioscience AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
1,777
|
0
|
865 |
Financial expenses |
0
![]() |
0
|
1 |
Earnings before taxes |
-11,228
|
-12,950
|
-6,664 |
EBITDA |
-11,283
|
-12,959
|
-6,663 |
Total assets |
6,280
|
13,080
|
22,813 |
Current assets |
4,996
|
11,818
|
9,043 |
Current liabilities |
2,480
|
1,868
|
1,615 |
Equity capital |
3,800
|
11,212
|
21,198 |
- share capital |
777
|
690
|
609 |
Employees (average) |
6
![]() |
6
|
5 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
60.5%
|
85.7%
|
92.9% |
Turnover per employee |
296
|
0
|
173 |
Profit as a percentage of turnover | -631.9% | -770.4% | |
Return on assets (ROA) |
-178.8%
|
-99.0%
|
-29.2% |
Current ratio |
201.5%
|
632.7%
|
559.9% |
Return on equity (ROE) |
-295.5%
|
-115.5%
|
-31.4% |
Change turnover |
1,777
|
-795
|
865 |
Change turnover % | -100% | ||
Chg. No. of employees |
0
|
1
|
0 |
Chg. No. of employees % |
0%
|
20%
|
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.